Sigyn Therapeutics, Inc. (SIGY)
Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise currently in its development phase. The company's core innovation is Sigyn Therapy, an advanced blood purification system designed to overcome the limitations of existing drugs and medical devices used to treat severe inflammatory disorders. A key focus is on sepsis, which represents a major cause of hospital-related deaths. Furthermore, Sigyn Therapeutics is actively evaluating the potential of Sigyn Therapy to address a broad spectrum of other therapeutic targets, including bacterial endotoxins, peptidoglycan, and lipoteichoic acid; various viral pathogens; harmful hepatic toxins; CytoVesicles; and significant pro-inflammatory cytokines such as tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6. The company is headquartered in San Diego, California.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Biotechnology
Sigyn Therapeutics, Inc.
OTC:SIGYHealthcare · Biotechnology
-23.22%$0.0304
Mkt Cap$49K
Float559K
O/S1.61M
Inst Own3.3%
SI0.4%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$3.36M
Total Assets$108K
Free Cash Flow-$852K
Debt & Equity
Total Debt$3.06M
Total Equity-$6.44M
Shares Outstanding
Short Interest
Split History3 splits · 2 reverse
2-year cumulative
1:40
Nasdaq bars a compliance period at 1:250
- 1:40Reverse splitMay 19, 202640 shares → 1
- 1:40Reverse splitJan 31, 202440 shares → 1
- 3:1Forward splitOct 19, 20041 share → 3
Balance Sheet Details
Assets$108K
Liabilities$6.55M
Accounts Receivable$0
Accounts Payable$847K
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $143K | $28K | $1.28M | $1.8M | $29K | $43K |
| YoY Growth | - | - | - | - | - | - | 405.6% | -97.8% | -28.8% | 6078.6% | -32.3% | - |
| Cost of Revenue | $1K | $6K | $9K | $10K | $536 | $11K | $36K | $10K | $512K | $1.03M | $10K | $25K |
| Gross Profit | -$1K | -$6K | -$9K | -$10K | -$536 | -$11K | $108K | $19K | $772K | $771K | $19K | $18K |
| Gross Margin | - | - | - | - | - | - | 75.1% | 65.7% | 60.1% | 42.7% | 66.0% | 41.5% |
| Research and Development | $79K | $773K | $798K | $658K | $734K | $27K | $0 | $0 | $0 | $0 | $0 | $0 |
| Selling, General, and Administrative | $1.71M | $1.75M | $1.66M | $1.49M | $1.27M | $889K | $626K | $1.02M | $3.21M | $1.48M | $2.27M | $405K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $1.78M | $2.52M | $2.46M | $2.15M | $2.01M | $916K | $626K | $1.02M | $3.21M | $1.48M | $2.27M | $405K |
| Operating Income (EBIT) | -$1.79M | -$2.52M | -$2.46M | -$2.15M | -$2.01M | -$916K | -$518K | -$1M | -$2.43M | -$710K | -$2.25M | -$388K |
| Operating Margin | - | - | - | - | - | - | -361.4% | -3544.2% | -189.6% | -39.4% | -7714.3% | -898.0% |
| Interest Expense | $718K | $860K | $2.04M | $647K | $399K | $343K | $55K | $353K | $791K | $53K | $441K | $0 |
| Interest Income | $0 | $0 | $0 | $783 | $460 | $343 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$1.58M | -$821K | -$1.69M | -$783K | -$996K | -$343K | -$2.8M | -$1.3M | -$1.41M | -$121K | -$80K | $0 |
| Income Before Tax (EBT) | -$3.36M | -$3.34M | -$4.15M | -$2.93M | -$3M | -$1.26M | -$3.31M | -$2.3M | -$4.25M | -$832K | -$2.69M | -$388K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $800 | $800 | $3 | $0 | $0 |
| Net Income | -$3.36M | -$3.34M | -$4.15M | -$3.71M | -$3.4M | -$1.6M | -$3.13M | -$2.62M | -$4.25M | -$832K | -$2.69M | -$388K |
| Net Income Margin | - | - | - | - | - | - | -2183.8% | -9243.2% | -331.0% | -46.1% | -9224.9% | -898.0% |
| Supplementary Data | ||||||||||||
| EPS | -2.09 | -2.51 | -3.77 | -3.97 | -0.09 | -0.22 | -5.78 | -6.04 | -13.54 | -4.64 | -11.77 | -2.08 |
| Diluted EPS | -2.09 | -2.51 | -3.77 | -3.97 | -0.09 | -0.22 | -5.78 | -6.04 | -13.54 | -4.64 | -11.77 | -2.08 |
| Weighted Average OS | 1.61M | 1.33M | 1.10M | 934,000 | 36.40M | 7.35M | 541,843 | 433,820 | 313,971 | 179,132 | 228,831 | 186,354 |
| EBITDA | -$1.78M | -$3.33M | -$2.45M | -$2.14M | -$2.53M | -$905K | $74K | -$1.7M | -$2.82M | -$549K | -$692K | -$388K |
| EBITDA Margin | - | - | - | - | - | - | 51.5% | -6011.9% | -219.4% | -30.4% | -2368.0% | -898.0% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Assets | ||||||||||||
| Current Assets | ||||||||||||
| Cash and Cash Equivalents | $20K | $12K | $12K | $8K | $341K | $84K | $500 | $7K | $10K | $150K | $639K | $95 |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $20K | $12K | $12K | $8K | $341K | $84K | $500 | $7K | $10K | $150K | $639K | $95 |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2K | $10K | $0 | $26K | $9K |
| Inventory | $0 | $0 | $50K | $50K | $50K | $0 | $0 | $724K | $726K | $724K | $510K | $423K |
| Other Current Assets | $37K | $9K | $56K | $12K | $2K | $0 | $0 | $0 | $0 | $0 | $1.07M | $0 |
| Total Current Assets | $58K | $21K | $118K | $70K | $393K | $670K | $589K | $733K | $761K | $875K | $1.16M | $484K |
| Long-Term Assets | ||||||||||||
| Property, Plant & Equipment Net | $0 | $122K | $183K | $240K | $291K | $2K | $3K | $16K | $25K | $38K | $5K | $3K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $482K | $482K | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $2K | $6K | $22K | $50K | $113K | $803K | $947K | $260K | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $50K | $71K | $21K | $21K | $21K | $0 | $0 | $0 | $0 | $0 | $0 | $75K |
| Total Long-Term Assets | $50K | $192K | $204K | $263K | $317K | $24K | $54K | $129K | $1.31M | $1.47M | $265K | $78K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $108K | $214K | $322K | $333K | $710K | $694K | $642K | $862K | $2.07M | $2.34M | $1.43M | $562K |
| Liabilities | ||||||||||||
| Current Liabilities | ||||||||||||
| Accounts Payable | $847K | $608K | $462K | $328K | $40K | $16K | $10K | $23K | $73K | $32K | $577K | $0 |
| Short-Term Debt | $912K | $2.07M | $2.21M | $1.64M | $693K | $519K | $1.9M | $1.84M | $1.23M | $589K | $501K | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $1K | $60K | $1.17M | $22K | $81K | $79K | $0 | $0 |
| Other Current Liabilities | $317K | $2K | $83K | $1K | -$46K | $523 | $27K | $1.46M | $942K | $2.06M | -$97K | $0 |
| Total Current Liabilities | $4.4M | $4.61M | $3.61M | $2.05M | $734K | $595K | $3.1M | $4.58M | $4.16M | $3M | $1.5M | $463K |
| Long-Term Liabilities | ||||||||||||
| Long-Term Debt | $2.15M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $31K | $13K | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $2.15M | $56K | $126K | $187K | $241K | $0 | $0 | $1.86M | $1.51M | $31K | $13K | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.86M | -$1.51M | $0 | $0 | $0 |
| Total Liabilities | $6.55M | $4.67M | $3.73M | $2.24M | $975K | $595K | $3.1M | $4.58M | $4.16M | $3.03M | $1.51M | $463K |
| Stockholders' Equity | ||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $163 | $161 | $129 | $4K | $4K | $4K | $8K | $8K | $5K | $4K | $3K | $3K |
| Retained Earnings | -$18.05M | -$14.68M | -$11.34M | -$7.2M | -$4.27M | -$1.26M | -$16.08M | -$13M | -$10.38M | -$6.13M | -$3.33M | -$632K |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | -$0 | -$0 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $11.61M | $10.22M | $7.93M | $5.29M | $4M | $1.36M | $13.61M | $9.28M | $8.28M | $5.43M | $3.24M | $729K |
| Total Equity | -$6.44M | -$4.46M | -$3.41M | -$1.9M | -$265K | $99K | -$2.46M | -$3.72M | -$2.09M | -$692K | -$82K | $99K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $108K | $214K | $322K | $333K | $710K | $694K | $642K | $862K | $2.07M | $2.34M | $1.43M | $562K |
| Supplementary Data | ||||||||||||
| Total Debt | $3.06M | $2.19M | $2.4M | $1.88M | $980K | $519K | $1.9M | $1.84M | $1.23M | $619K | $13K | $0 |
| Net Debt | $3.04M | $2.18M | $2.39M | $1.87M | $639K | $434K | $1.9M | $1.83M | $1.22M | $470K | -$626K | -$95 |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Operating Activities | ||||||||||||
| Net Income | -$3.36M | -$3.34M | -$4.15M | -$2.93M | -$3M | -$1.26M | -$3.34M | -$2.62M | -$4.25M | -$832K | -$2.69M | -$388K |
| Depreciation & Amortization | $1K | $6K | $9K | $10K | $19K | $11K | $75K | $247K | $236K | $86K | $1K | $0 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | -$260K | $947K | $1.03M | $0 | $61K | $0 |
| Stock-Based Compensation | $0 | $150K | $216K | $0 | $0 | $0 | $4K | $10K | $62K | $0 | $1.4M | $0 |
| Changes in Working Capital: | ||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | -$34K | $8K | -$10K | $5K | -$29K | -$1K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $135K | $3K | -$3K | $1K | $10K | $25K |
| Accounts Payable | $239K | $147K | $197K | $288K | $24K | $15K | -$12K | -$139K | $177K | $334K | $191K | $0 |
| Other Working Capital | $453K | $1.12M | $653K | $19K | -$58K | $60K | $260K | $674K | $498K | $222K | $230K | $280K |
| Total Working Capital Change | $692K | $1.26M | $850K | $307K | -$34K | $75K | $349K | $545K | $663K | $563K | $402K | $304K |
| Other Non-Cash Items | $1.82M | $1.05M | $1.69M | $782K | $1.25M | $343K | $2.77M | $584K | $1.87M | -$117K | $751K | $39K |
| Net Cash from Operating | -$852K | -$872K | -$1.38M | -$1.83M | -$1.77M | -$830K | -$144K | -$286K | -$400K | -$131K | -$84K | -$44K |
| Investing Activities | ||||||||||||
| Capital Expenditures | $0 | $0 | $0 | -$860 | -$29K | -$11K | $0 | -$8K | -$79K | -$118K | -$12K | -$3K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $100K | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | -$11 | $100K | -$8K | -$79K | -$106K | -$12K | $0 |
| Net Cash from Investing | $0 | $0 | $0 | -$860 | -$29K | -$11K | $100K | -$8K | -$79K | -$118K | -$12K | -$3K |
| Financing Activities | ||||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | - | - | -$725K | - |
| Common Stock Issuance | $0 | $0 | $0 | $0 | $1.86M | $396K | $0 | $206K | $0 | $200K | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$9K | -$80K | $75K | -$68K | $0 | $925K | $37K | $0 | $0 | $209K | $0 | $48K |
| Net Cash from Financing | $860K | $873K | $1.39M | $1.5M | $2.06M | $925K | $37K | $292K | $339K | $209K | $735K | $48K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $8K | $454 | $3K | -$333K | $257K | $84K | -$7K | -$2K | -$140K | -$192K | $639K | $95 |
| Supplementary Data | ||||||||||||
| Operating Cash Flow | -$852K | -$872K | -$1.38M | -$1.83M | -$1.77M | -$830K | -$144K | -$286K | -$400K | -$131K | -$84K | -$44K |
| Capital Expenditure | -$5 | $0 | $0 | -$860 | -$29K | -$11K | $0 | -$8K | -$79K | -$118K | -$12K | -$3K |
| Free Cash Flow | -$852K | -$872K | -$1.38M | -$1.83M | -$1.8M | -$841K | -$144K | -$295K | -$479K | -$249K | -$96K | -$48K |
| Cash at Beginning | $12K | $12K | $8K | $341K | $84K | $0 | $7K | $10K | $150K | $342K | $95 | $0 |
| Cash at End | $20K | $12K | $12K | $8K | $341K | $84K | $500 | $7K | $10K | $150K | $639K | $95 |